retatrutide clinical trial dose escalation Side Effects Research Retatrutide: The New Triple-Agonist Weight

Sikiric et al., 2020a

A 2018 review described BPC-157 in relation to standard angiogenic growth factors, discussing tendon, ligament and bone healing models and angiogenic effects

So people at greatest risk for deficiency include those with low stomach acid (e.g., older adults and people on proton pump inhibitors or antacids) or low IF production (known as pernicious anemia), people on medications that interfere with B12 absorption (such as metformin), people who have had gastric surgery, those with GI conditions that impair nutrient absorption (like celiac or Crohn's disease), and people on vegan and vegetarian diets

Characterization of basal pseudopod-like processes in ileal and colonic PYY cells

Both work through separate receptor systems

C.GreenP